• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    FitLife Brands Announces First Quarter 2024 Results

    5/14/24 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $FTLF alert in real time by email

    Omaha, May 14, 2024 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2024.

    Highlights for the first quarter ended March 31, 2024 include:

    • Total revenue was $16.5 million, an increase of 54% compared to the first quarter of 2023.  
    • Online sales were $10.8 million, representing 65% of total revenue and an increase of 116% compared to the first quarter of 2023.
    • Gross margin was 44.0% compared to 41.1% during the first quarter of 2023.
    • Net income for the first quarter of 2024 was $2.2 million compared to $0.2 million during the same period last year.
    • Basic earnings per share and diluted earnings per share were $0.47 and $0.43, respectively, compared to $0.03 during the first quarter of 2023.
    • Adjusted EBITDA was $3.6 million, a 62% increase compared to the first quarter of 2023.
    • The Company ended the quarter with $16.5 million outstanding on its term loans and cash of $3.3 million, or total net debt of $13.2 million.



    For the first quarter ended March 31, 2024, total revenue was $16.5 million, an increase of 54% compared to $10.7 million during the same period last year. Online revenue for the quarter was $10.8 million, an increase of 116% compared to the quarter ended March 31, 2023. Online sales for legacy FitLife increased 3% during the quarter compared to the same period last year. Online revenue accounted for 65% and 47% of the Company's total revenue during the quarters ended March 31, 2024 and 2023, respectively.

    Wholesale revenue for the quarter ended March 31, 2024 was $5.7 million, flat when compared to the same period last year.   The Company's recent acquisitions contributed $1.2 million of wholesale revenue during the first quarter of 2024, while Legacy FitLife wholesale revenue was down $1.2 million, or 21%, compared to the same period last year.  

    Gross margin for the quarter ended March 31, 2024 was 44.0% compared to 41.1% during the same period in the prior year. Excluding the impact of the inventory step-up resulting from the acquisition of Mimi's Rock Corp ("MRC"), gross margin during the quarter ended March 31, 2023 would have been 42.1%.

    Net income for the first quarter of 2024 was $2.2 million compared to $0.2 million during the quarter ended March 31, 2023. Basic earnings per share and diluted earnings per share were $0.47 and $0.43 respectively, compared to $0.03 during the first quarter of 2023. Net income during the first quarter of 2023 was adversely impacted by a number of acquisition-related items that did not recur in 2024 including transaction expenses of $1.4 million, amortization of the inventory step-up valuation of $0.1 million, and a loss on a currency hedge of $0.1 million.

    Adjusted EBITDA for the quarter ended March 31, 2024 was $3.6 million, an increase of 62% compared to the same period in 2023.  

    The Company ended the quarter with $16.5 million outstanding on its term loans and cash of $3.3 million, or total net debt of $13.2 million. As previously disclosed, the Company made a voluntary paydown on its term loan of $2.5 million during the first quarter of 2024 in addition to the scheduled amortization payment of $1.1 million.

    Dayton Judd, the Company's Chairman and CEO, commented "The Company is off to a solid start in 2024 and there are many bright spots in our business. At MRC, I am encouraged that the Dr. Tobias brand—which represents approximately 90% of the MRC business—returned to growth during the quarter despite advertising spend that was 39% lower than in the first quarter of 2023. And although the skin care brands continue to struggle on the top line, they are more profitable now than they were at the time of the acquisition. In total, MRC is significantly more profitable than when we made the acquisition.

    "Our legacy FitLife brands continue to face headwinds in the wholesale channel due to declining foot traffic at our brick-and-mortar retail partners. Although the declines were partially offset by growth in the legacy FitLife online business, the online growth rate we experienced during the first quarter was lower than anticipated. We are encouraged, though, that the growth rate for legacy FitLife online sales was much stronger during April with a 13% year-over-year increase.

    "In addition, I am excited about a number of new products that we will be introducing this year across several of our brands. Of note, we recently re-launched the MusclePharm Combat Sport protein bar in April 2024. We believe the MusclePharm brand is our most significant organic growth opportunity. Both online and wholesale revenue for MusclePharm ramped up throughout the quarter, and we hope to continue the momentum. Overall, our first quarter results demonstrate that we are continuing to execute our goal of profitably growing revenue and paying down debt."

    The Company will hold an investor conference call on Tuesday, May 14, 2024 at 4:30 pm ET. Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 629005. International participants can dial (973) 528-0163 and provide the same code.

    About FitLife Brands

    FitLife Brands is a developer and marketer of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers. FitLife markets more than 250 different products primarily online, but also through domestic and international GNC® franchise locations as well as through approximately 16,000 additional domestic retail locations. FitLife is headquartered in Omaha, Nebraska. For more information, please visit our website at www.fitlifebrands.com.

    Forward-Looking Statements

    Statements in this release that are forward looking involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to, the ability of the Company to continue to grow revenue, and the Company's ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in the Company's filings with the Securities and Exchange Commission including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

    Non-GAAP Financial Measures 

      

    The financial presentation below contains certain financial measures defined as "non-GAAP financial measures" by the SEC, including non-GAAP EBITDA and non-GAAP adjusted EBITDA. These measures may be different from non-GAAP financial measures used by other companies. The presentation of this financial information, which is not prepared under any comprehensive set of accounting rules or principles, is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. 

      

    As presented below, non-GAAP EBITDA excludes interest, income taxes, and depreciation and amortization and foreign currency gain/loss. Adjusted non-GAAP EBITDA excludes—in addition to interest, taxes, depreciation and amortization—equity-based compensation, M&A/integration expense, restatement-related expense and non-recurring gains or losses. The Company believes the non-GAAP measures provide useful information to both management and investors by excluding certain expense and other items that may not be indicative of its core operating results and business outlook. The Company believes that the inclusion of non-GAAP measures in the financial presentation below allows investors to compare the Company's financial results with the Company's historical financial results and is an important measure of the Company's comparative financial performance. 



     

     

    FITLIFE BRANDS, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (In thousands, except per share data)

      March 31, 2024  December 31, 2023 
      (Unaudited)     
    ASSETS:        
    CURRENT ASSETS        
    Cash and cash equivalents $2,540  $1,139 
    Restricted cash  750   759 
    Accounts receivable, net of allowance of doubtful accounts of $18 and $17, respectively  2,269   2,046 
    Inventories, net of allowance for obsolescence of $139 and $162, respectively  8,869   9,091 
    Sales tax receivable  113   1,019 
    Prepaid expense and other current assets  451   639 
    Total current assets  14,992   14,693 
             
    Property and equipment, net  121   137 
    Right of use asset  96   121 
    Intangibles, net of amortization of $124 and $113, respectively  26,325   26,309 
    Goodwill  13,340   13,294 
    Deferred tax asset  612   792 
    TOTAL ASSETS $55,486  $55,346 
             
    LIABILITIES AND STOCKHOLDERS' EQUITY:        
    CURRENT LIABILITIES:        
    Accounts payable $3,978  $3,261 
    Accrued expense and other liabilities  1,397   1,026 
    Income taxes payable  1,356   892 
    Product returns  524   571 
    Term loan – current portion  4,500   4,500 
    Lease liability - current portion  73   87 
    Total current liabilities  11,828   10,337 
             
    Term loan, net of current portion and unamortized deferred finance costs  11,894   15,509 
    Long-term lease liability, net of current portion  34   51 
    Deferred tax liability  2,353   2,413 
    TOTAL LIABILITIES  26,109   28,310 
             
    STOCKHOLDERS' EQUITY:        
    Preferred stock, $0.01 par value, 10,000 shares authorized, none outstanding as of March 31, 2024 and December 31, 2023  -   - 
    Common stock, $0.01 par value, 60,000 shares authorized; 4,598 issued and outstanding as of March 31, 2024 and December 31, 2023  46   46 
    Additional paid-in capital  30,801   30,699 
    Accumulated deficit  (1,257)  (3,417)
    Foreign currency translation adjustment  (213)  (292)
    TOTAL STOCKHOLDERS' EQUITY  29,377   27,036 
    TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $55,486  $55,346 

    FITLIFE BRANDS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

    FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023

    (In thousands, except per share data)

    (Unaudited)

      Three months ended March 31, 
      2024  2023 
             
    Revenue $16,549  $10,738 
    Cost of goods sold  9,262   6,330 
    Gross profit  7,287   4,408 
             
    OPERATING EXPENSE:        
    Selling, general and administrative  3,736   2,344 
    Merger and acquisition related expense  134   1,372 
    Depreciation and amortization  36   19 
    Total operating expense  3,906   3,735 
             
    OPERATING INCOME  3,381   673 
             
    OTHER EXPENSE (INCOME)        
    Interest income  (5)  (84)
    Interest expense  414   98 
    Foreign exchange (gain) loss  5   82 
    Total other expense (income)  414   96 
             
    INCOME BEFORE INCOME TAX PROVISION  2,967   577 
             
    PROVISION FOR INCOME TAXES  807   421 
             
    NET INCOME $2,160  $156 
             
    NET INCOME PER SHARE        
    Basic $0.47  $0.03 
    Diluted $0.43  $0.03 
    Basic weighted average common shares  4,598   4,483 
    Diluted weighted average common shares  5,030   4,935 
             
    COMPREHENSIVE INCOME:        
    NET INCOME $2,160  $156 
    Foreign currency translation adjustment  79   - 
    Comprehensive income $2,239  $156 

    FITLIFE BRANDS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023

    (In thousands)

    (Unaudited)

      Three months ended March 31, 
      2024  2023 
             
    CASH FLOWS FROM OPERATING ACTIVITIES:        
    Net income $2,160  $156 
    Adjustments to reconcile net income to net cash provided by operating activities:        
    Depreciation and amortization  36   19 
    Allowance for doubtful accounts  1   (14)
    Allowance for inventory obsolescence  (23)  2 
    Stock compensation expense  102   42 
    Amortization of deferred financing costs  10   1 
    Changes in operating assets and liabilities:        
    Accounts receivable - trade  (242)  (917)
    Inventories  218   1,501 
    Deferred tax asset  180   251 
    Prepaid expense, other assets and sales tax receivable  1,067   (44)
    Right of use asset  21   16 
    Accounts payable  727   (1,045)
    Lease liability  (30)  (16)
    Accrued liabilities, other liabilities and income taxes payable  856   289 
    Product returns  (47)  (9)
    Net cash provided by operating activities  5,036   232 
             
    CASH FLOWS FROM INVESTING ACTIVITIES:        
    Purchase of property and equipment  (10)  - 
    Cash paid for acquisition of Mimi's Rock Corp.  -   (17,099)
    Net cash used in investing activities  (10)  (17,099)
             
    CASH FLOWS FROM FINANCING ACTIVITIES:        
    Payments on term loans  (3,625)  - 
    Borrowings on term loan  -   12,500 
    Net cash provided by (used in) financing activities  (3,625)  12,500 
             
    Foreign currency impact on cash  (9)  17 
             
    CHANGE IN CASH AND RESTRICTED CASH  1,392   (4,350)
    CASH, BEGINNING OF PERIOD  1,898   13,277 
    CASH AND RESTRICTED CASH, END OF PERIOD $3,290  $8,927 





    [email protected]

    Primary Logo

    Get the next $FTLF alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $FTLF

    DatePrice TargetRatingAnalyst
    3/17/2025$21.00Buy
    Lake Street
    9/3/2024$40.00Buy
    ROTH MKM
    More analyst ratings

    $FTLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Hansen Ryan P. claimed ownership of 25,678 shares (SEC Form 3)

      3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      5/12/25 7:27:11 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 3 filed by new insider Pappas Shannon K.

      3 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      5/12/25 7:26:27 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:07 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on FitLife Brands with a new price target

      Lake Street initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $21.00

      3/17/25 8:22:47 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • ROTH MKM initiated coverage on FitLife Brands with a new price target

      ROTH MKM initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $40.00

      9/3/24 7:48:49 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • FitLife Brands Announces First Quarter 2025 Results

      OMAHA, NE, May 15, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2025. Highlights for the first quarter ended March 31, 2025 include: Total revenue was $15.9 million, 4% lower than the first quarter of 2024.  Online sales were $10.6 million, representing 67% of total revenue and down 2% compared to the first quarter of 2024.Gross margin was 43.1% compared to 44.0% during the first quarter of 2024.Net income for the first quarter of 2025 was $2.0 million compared to $2.2 million during th

      5/15/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces First Quarter Earnings Call

      OMAHA, NE, May 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the first quarter of fiscal 2025 on Thursday, May 15, 2025. In addition, the Company announced that it will hold an investor conference call after market close on May 15, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 577011.  International participants can dial (973) 528-0163 and provide the same code. About

      5/5/25 3:00:00 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Board Transition

      Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a member of the Company's Board of Directors. Mr. Ordal's resignation, effective on April 25, 2025, was part of the Company's ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company's management or the Board of Directors regarding any matter related to the Company or otherwise. On April 25, 2025, the Board of Directors of

      4/28/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    SEC Filings

    See more
    • SEC Form DEFA14A filed by FitLife Brands Inc.

      DEFA14A - FITLIFE BRANDS, INC. (0001374328) (Filer)

      6/24/25 5:00:20 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form DEF 14A filed by FitLife Brands Inc.

      DEF 14A - FITLIFE BRANDS, INC. (0001374328) (Filer)

      6/24/25 5:00:10 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form DEFA14A filed by FitLife Brands Inc.

      DEFA14A - FITLIFE BRANDS, INC. (0001374328) (Filer)

      6/24/25 5:00:01 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:07 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Lingenbrink Matthew bought $36,510 worth of shares (3,000 units at $12.17), increasing direct ownership by 107% to 5,800 units (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/16/25 8:00:05 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Lingenbrink Matthew bought $34,089 worth of shares (2,800 units at $12.17) (SEC Form 4)

      4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

      4/2/25 8:01:06 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    Financials

    Live finance-specific insights

    See more
    • FitLife Brands Announces First Quarter 2025 Results

      OMAHA, NE, May 15, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2025. Highlights for the first quarter ended March 31, 2025 include: Total revenue was $15.9 million, 4% lower than the first quarter of 2024.  Online sales were $10.6 million, representing 67% of total revenue and down 2% compared to the first quarter of 2024.Gross margin was 43.1% compared to 44.0% during the first quarter of 2024.Net income for the first quarter of 2025 was $2.0 million compared to $2.2 million during th

      5/15/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces First Quarter Earnings Call

      OMAHA, NE, May 05, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the first quarter of fiscal 2025 on Thursday, May 15, 2025. In addition, the Company announced that it will hold an investor conference call after market close on May 15, 2025 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 577011.  International participants can dial (973) 528-0163 and provide the same code. About

      5/5/25 3:00:00 PM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • FitLife Brands Announces Fourth Quarter and Full-Year 2024 Results

      Omaha, March 27, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the fourth quarter and full year ended December 31, 2024. Highlights for the fourth quarter ended December 31, 2024 include: Total revenue was $15.0 million, an increase of 13% compared to the fourth quarter of 2023.  Online sales were $10.1 million, representing 67% of total revenue and an increase of 12% compared to the fourth quarter of 2023.Gross margin was 41.4% compared to 40.3% during the fourth quarter of 2023.Net income was $2.1 million compared to $

      3/27/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care

    $FTLF
    Leadership Updates

    Live Leadership Updates

    See more
    • FitLife Brands Announces Board Transition

      Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a member of the Company's Board of Directors. Mr. Ordal's resignation, effective on April 25, 2025, was part of the Company's ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company's management or the Board of Directors regarding any matter related to the Company or otherwise. On April 25, 2025, the Board of Directors of

      4/28/25 7:30:00 AM ET
      $FTLF
      Medicinal Chemicals and Botanical Products
      Health Care
    • LifeVantage Appoints Dayton Judd to the Board of Directors

      SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company's Board of Directors (the "Board"), effective immediately, in an expansion of the Board. The Company has had discussions with Bradley L. Radoff and Sudbury Capital Fund, LP (collectively with certain of their affiliates, the "Radoff-Sudbury Group"), which owns approximately 12.6% of the Company's outstanding stock, since the Company's fiscal year 2024 annual meeting of shareholders held on November 6, 2023. During these dis

      2/15/24 4:05:00 PM ET
      $FTLF
      $LFVN
      $OPXS
      Medicinal Chemicals and Botanical Products
      Health Care
      Biotechnology: Pharmaceutical Preparations
      Electronic Components